Paying users zone. Data is covered by .

  • Get to Eli Lilly & Co. for $15.99, or

  • get to whole website for at least 3 months from $49.99.

 

$15.99


Ratios (Summary)

Eli Lilly & Co., profitability ratios

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Return on Sales
Gross profit margin % % % % %
Operating profit margin % % % % %
Net profit margin % % % % %
Return on Investment
Return on equity (ROE) % % % % %
Return on assets (ROA) % % % % %

Source: Based on data from Eli Lilly & Co. Annual Reports

Ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. Eli Lilly & Co.'s gross profit margin deteriorated from 2015 to 2016 but then slightly improved from 2016 to 2017.
Operating profit margin A profitability ratio calculated as operating income divided by revenue. Eli Lilly & Co.'s operating profit margin improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.
Net profit margin An indicator of profitability, calculated as net income divided by revenue. Eli Lilly & Co.'s net profit margin improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.
ROE A profitability ratio calculated as net income divided by shareholders' equity. Eli Lilly & Co.'s ROE improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.
ROA A profitability ratio calculated as net income divided by total assets. Eli Lilly & Co.'s ROA improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.

Top


Gross Profit Margin

Eli Lilly & Co., gross profit margin calculation

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in thousands)
Gross margin
Revenue
Ratio
Gross profit margin1 % % % % %
Benchmarks
Gross Profit Margin, Competitors
Abbott Laboratories % % % % %
AbbVie Inc. % % % % %
Allergan PLC % % % % %
Amgen Inc. % % % % %
Biogen Inc. % % % % %
Bristol-Myers Squibb Co. % % % % %
Celgene Corp. % % % % %
Gilead Sciences Inc. % % % % %
Johnson & Johnson % % % % %
Merck & Co. Inc. % % % % %
Pfizer Inc. % % % % %
Regeneron Pharmaceuticals Inc. % % % % %

Source: Based on data from Eli Lilly & Co. Annual Reports

2017 Calculations

1 Gross profit margin = 100 × Gross margin ÷ Revenue
= 100 × ÷ = %

Ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. Eli Lilly & Co.'s gross profit margin deteriorated from 2015 to 2016 but then slightly improved from 2016 to 2017.

Top


Operating Profit Margin

Eli Lilly & Co., operating profit margin calculation, comparison to benchmarks

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in thousands)
Operating income
Revenue
Ratio
Operating profit margin1 % % % % %
Benchmarks
Operating Profit Margin, Competitors
Abbott Laboratories % % % % %
AbbVie Inc. % % % % %
Allergan PLC % % % % %
Amgen Inc. % % % % %
Biogen Inc. % % % % %
Bristol-Myers Squibb Co. % % % % %
Celgene Corp. % % % % %
Gilead Sciences Inc. % % % % %
Johnson & Johnson % % % % %
Merck & Co. Inc. % % % % %
Pfizer Inc. % % % % %
Regeneron Pharmaceuticals Inc. % % % % %
Operating Profit Margin, Sector
Pharmaceuticals & Biotechnology % % % % %
Operating Profit Margin, Industry
Health Care % % % % %

Source: Based on data from Eli Lilly & Co. Annual Reports

2017 Calculations

1 Operating profit margin = 100 × Operating income ÷ Revenue
= 100 × ÷ = %

Ratio Description The company
Operating profit margin A profitability ratio calculated as operating income divided by revenue. Eli Lilly & Co.'s operating profit margin improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.

Top


Net Profit Margin

Eli Lilly & Co., net profit margin calculation, comparison to benchmarks

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in thousands)
Net income (loss)
Revenue
Ratio
Net profit margin1 % % % % %
Benchmarks
Net Profit Margin, Competitors
Abbott Laboratories % % % % %
AbbVie Inc. % % % % %
Allergan PLC % % % % %
Amgen Inc. % % % % %
Biogen Inc. % % % % %
Bristol-Myers Squibb Co. % % % % %
Celgene Corp. % % % % %
Gilead Sciences Inc. % % % % %
Johnson & Johnson % % % % %
Merck & Co. Inc. % % % % %
Pfizer Inc. % % % % %
Regeneron Pharmaceuticals Inc. % % % % %
Net Profit Margin, Sector
Pharmaceuticals & Biotechnology % % % % %
Net Profit Margin, Industry
Health Care % % % % %

Source: Based on data from Eli Lilly & Co. Annual Reports

2017 Calculations

1 Net profit margin = 100 × Net income (loss) ÷ Revenue
= 100 × ÷ = %

Ratio Description The company
Net profit margin An indicator of profitability, calculated as net income divided by revenue. Eli Lilly & Co.'s net profit margin improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.

Top


Return on Equity (ROE)

Eli Lilly & Co., ROE calculation, comparison to benchmarks

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in thousands)
Net income (loss)
Total Eli Lilly and Company shareholders' equity
Ratio
ROE1 % % % % %
Benchmarks
ROE, Competitors
Abbott Laboratories % % % % %
AbbVie Inc. % % % % %
Allergan PLC % % % % %
Amgen Inc. % % % % %
Biogen Inc. % % % % %
Bristol-Myers Squibb Co. % % % % %
Celgene Corp. % % % % %
Gilead Sciences Inc. % % % % %
Johnson & Johnson % % % % %
Merck & Co. Inc. % % % % %
Pfizer Inc. % % % % %
Regeneron Pharmaceuticals Inc. % % % % %
ROE, Sector
Pharmaceuticals & Biotechnology % % % % %
ROE, Industry
Health Care % % % % %

Source: Based on data from Eli Lilly & Co. Annual Reports

2017 Calculations

1 ROE = 100 × Net income (loss) ÷ Total Eli Lilly and Company shareholders' equity
= 100 × ÷ = %

Ratio Description The company
ROE A profitability ratio calculated as net income divided by shareholders' equity. Eli Lilly & Co.'s ROE improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.

Top


Return on Assets (ROA)

Eli Lilly & Co., ROA calculation, comparison to benchmarks

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in thousands)
Net income (loss)
Total assets
Ratio
ROA1 % % % % %
Benchmarks
ROA, Competitors
Abbott Laboratories % % % % %
AbbVie Inc. % % % % %
Allergan PLC % % % % %
Amgen Inc. % % % % %
Biogen Inc. % % % % %
Bristol-Myers Squibb Co. % % % % %
Celgene Corp. % % % % %
Gilead Sciences Inc. % % % % %
Johnson & Johnson % % % % %
Merck & Co. Inc. % % % % %
Pfizer Inc. % % % % %
Regeneron Pharmaceuticals Inc. % % % % %
ROA, Sector
Pharmaceuticals & Biotechnology % % % % %
ROA, Industry
Health Care % % % % %

Source: Based on data from Eli Lilly & Co. Annual Reports

2017 Calculations

1 ROA = 100 × Net income (loss) ÷ Total assets
= 100 × ÷ = %

Ratio Description The company
ROA A profitability ratio calculated as net income divided by total assets. Eli Lilly & Co.'s ROA improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.

Top